Clinical trial: NCT03827109
Section: Alternatives
Subsections: 6) Are There Benefits To Taking Part In This Study?|6) Are There Benefits To Taking Part In This Study?|6) Are There Benefits To Taking Part In This Study?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|6) Are There Benefits To Taking Part In This Study?|6) Are There Benefits To Taking Part In This Study?|6) Are There Benefits To Taking Part In This Study?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|6) Are There Benefits To Taking Part In This Study?|6) Are There Benefits To Taking Part In This Study?|6) Are There Benefits To Taking Part In This Study?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?|7) What Other Treatments Or Options Are There?

You might learn new things about IBD and how to manage it, and you might meet other supportive people. Also, we might learn something that could help others.

You might learn new things about IBD and how to manage it, and you might meet other supportive people. You might help someone else learn how to better manage the impact of IBD. Also, we might learn something that could help others.

You might learn new things about IBD and how to manage it, and you might meet other supportive people. You might help someone else learn how to better manage the impact of IBD. Also, we might learn something that could help others.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. Other treatments such as usual IBD care and psychotherapy are available. If you decide not to be in this study, the Principal Investigator will talk to you about other treatments or refer you to your regular doctor for care.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.  
STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
There are no costs or reimbursements associated with this application phase of the study.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.

You might learn new things about IBD and how to manage it, and you might meet other supportive people. Also, we might learn something that could help others.

You might learn new things about IBD and how to manage it, and you might meet other supportive people. You might help someone else learn how to better manage the impact of IBD. Also, we might learn something that could help others.

You might learn new things about IBD and how to manage it, and you might meet other supportive people. You might help someone else learn how to better manage the impact of IBD. Also, we might learn something that could help others.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. Other treatments such as usual IBD care and psychotherapy are available. If you decide not to be in this study, the Principal Investigator will talk to you about other treatments or refer you to your regular doctor for care.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.  
STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
There are no costs or reimbursements associated with this application phase of the study.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. Other treatments such as usual IBD care and psychotherapy are available. If you decide not to be in this study, the Principal Investigator will talk to you about other treatments or refer you to your regular doctor for care.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.  
STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
There are no costs or reimbursements associated with this application phase of the study.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.

You might learn new things about IBD and how to manage it, and you might meet other supportive people. Also, we might learn something that could help others.

You might learn new things about IBD and how to manage it, and you might meet other supportive people. You might help someone else learn how to better manage the impact of IBD. Also, we might learn something that could help others.

You might learn new things about IBD and how to manage it, and you might meet other supportive people. You might help someone else learn how to better manage the impact of IBD. Also, we might learn something that could help others.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. Other treatments such as usual IBD care and psychotherapy are available. If you decide not to be in this study, the Principal Investigator will talk to you about other treatments or refer you to your regular doctor for care.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.  
STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
There are no costs or reimbursements associated with this application phase of the study.

Your participation is this study is voluntary. It is not necessary to be in this study to get care for this condition. If you would like to be a mentor but are not interested in this study, you can apply to be a mentor with other organizations.
Clinical trial: NCT03827109
Section: Confidentiality
Subsections: Research Study:|Research Study:|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|People Or Companies Authorized To Use, Disclose, And Receive Phi Collected Or Created By This Research Study:|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|12) How Will My Study Information Be Kept Private?|Certificate Of Confidentiality

PI and study staff The Nationwide Children's Hospital Institutional Review Board (the committee that reviews all human subject research) Nationwide Children's Hospital internal auditors The Office for Human Research Protections (OHRP) (the federal government office that oversees human subject research) Because of the need to give information to these people, absolute confidentiality cannot be guaranteed. Information given to these people may no longer be protected by federal privacy rules. Reason(s) why the use or disclosure is being made: For mentoring program matching, supervision and other communication; to ensure appropriate and complete data collection You may decide not to authorize the use and disclosure of your PHI. However, if it is needed for this study, you will not be able to be in this study. If you agree to be in this study and later decide to withdraw your participation, you may withdraw your authorization to use your PHI. This request must be made in writing to the Principal Investigator at 700 Children's Drive, Columbus, Ohio 43205. If you withdraw your authorization, no new PHI may be collected and the PHI already collected may not be used unless it has already been used or is needed to complete the study analysis and reports. PHI will only be shared with the groups listed above, but if you have a bad outcome or adverse event from being in this study, the study team or other health care providers may need to look at your entire medical records. The results from this study may be published but your identity will not be revealed. The PHI collected or created under this research study will be used or disclosed as needed until the end of the study. The records of this study will be kept for an indefinite period of time and your authorization to use or disclose your PHI will not expire.

PI and study staff The Nationwide Children's Hospital Institutional Review Board (the committee that reviews all human subject research) Nationwide Children's Hospital internal auditors The Office for Human Research Protections (OHRP) (the federal government office that oversees human subject research)
Because of the need to give information to these people, absolute confidentiality cannot be guaranteed. Information given to these people may no longer be protected by federal privacy rules. Reason(s) why the use or disclosure is being made: For mentoring program matching, supervision and other communication; to ensure appropriate and complete data collection You may decide not to authorize the use and disclosure of your PHI. However, if it is needed for this study, you will not be able to be in this study. If you agree to be in this study and later decide to withdraw your participation, you may withdraw your authorization to use your PHI. This request must be made in writing to the Principal Investigator at 700 Children's Drive, Columbus, Ohio 43205. If you withdraw your authorization, no new PHI may be collected and the PHI already collected may not be used unless it has already been used or is needed to complete the study analysis and reports. PHI will only be shared with the groups listed above, but if you have a bad outcome or adverse event from being in this study, the study team or other health care providers may need to look at your entire medical records. The results from this study may be published but your identity will not be revealed.  
STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
The PHI collected or created under this research study will be used or disclosed as needed until the end of the study. The records of this study will be kept for an indefinite period of time and your authorization to use or disclose your PHI will not expire.

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study and for future research purposes (including purposes that are currently unknown) unless otherwise allowed by applicable laws. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers.

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this research study: PI and study staff The Nationwide Children's Hospital Institutional Review Board (the committee that reviews all human subject research) Nationwide Children's Hospital internal auditors The Office for Human Research Protections (OHRP) (the federal government office that oversees human subject research)  
  
  
Because of the need to give information to these people, absolute confidentiality cannot be guaranteed. Information given to these people may be further disclosed by them and no longer be protected by federal privacy rules. Reason(s) why the use or disclosure is being made: For mentoring program matching, supervision and other communication; to ensure appropriate and complete data collection You may decide not to authorize the use and disclosure of your PHI. However, if it is needed for this study, you will not be able to be in this study. If you agree to be in this study and later decide to withdraw your participation, you may withdraw your authorization to use your PHI. This request must be made in writing to the Principal Investigator at 700 Children's Drive, Columbus, Ohio 43205. If you withdraw your authorization, no new PHI may be collected and the PHI already collected may not be used unless it has already been used or is needed to complete the study analysis and reports. PHI will only be shared with the groups listed above, but if you have a bad outcome or adverse event from being in this study, the study team or other health care providers may need to look at your entire medical records. The results from this study may be published but your identity will not be revealed. The PHI collected or created under this research study will be used or disclosed as needed until the end of the study. The records of this study will be kept for an indefinite period of time and your authorization to use or disclose your PHI will not expire.

PI and study staff The Nationwide Children's Hospital Institutional Review Board (the committee that reviews all human subject research) Nationwide Children's Hospital internal auditors The Office for Human Research Protections (OHRP) (the federal government office that oversees human subject research) Because of the need to give information to these people, absolute confidentiality cannot be guaranteed. Information given to these people may no longer be protected by federal privacy rules. Reason(s) why the use or disclosure is being made: For mentoring program matching, supervision and other communication; to ensure appropriate and complete data collection You may decide not to authorize the use and disclosure of your PHI. However, if it is needed for this study, you will not be able to be in this study. If you agree to be in this study and later decide to withdraw your participation, you may withdraw your authorization to use your PHI. This request must be made in writing to the Principal Investigator at 700 Children's Drive, Columbus, Ohio 43205. If you  
  
  
withdraw your authorization, no new PHI may be collected and the PHI already collected may not be used unless it has already been used or is needed to complete the study analysis and reports. PHI will only be shared with the groups listed above, but if you have a bad outcome or adverse event from being in this study, the study team or other health care providers may need to look at your entire medical records. The results from this study may be published but your identity will not be revealed. The PHI collected or created under this research study will be used or disclosed as needed until the end of the study. The records of this study will be kept for an indefinite period of time and your authorization to use or disclose your PHI will not expire.

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study and for future research purposes (including purposes that are currently unknown) unless otherwise allowed by applicable laws. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers.

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this research study: PI and study staff The Nationwide Children's Hospital Institutional Review Board (the committee that reviews all human subject research) Nationwide Children's Hospital internal auditors The Office for Human Research Protections (OHRP) (the federal government office that oversees human subject research)  
  
  
Because of the need to give information to these people, absolute confidentiality cannot be guaranteed. Information given to these people may be further disclosed by them and no longer be protected by federal privacy rules. Reason(s) why the use or disclosure is being made: For mentoring program matching, supervision and other communication; to ensure appropriate and complete data collection You may decide not to authorize the use and disclosure of your PHI. However, if it is needed for this study, you will not be able to be in this study. If you agree to be in this study and later decide to withdraw your participation, you may withdraw your authorization to use your PHI. This request must be made in writing to the Principal Investigator at 700 Children's Drive, Columbus, Ohio 43205. If you withdraw your authorization, no new PHI may be collected and the PHI already collected may not be used unless it has already been used or is needed to complete the study analysis and reports. PHI will only be shared with the groups listed above, but if you have a bad outcome or adverse event from being in this study, the study team or other health care providers may need to look at your entire medical records. The results from this study may be published but your identity will not be revealed. The PHI collected or created under this research study will be used or disclosed as needed until the end of the study. The records of this study will be kept for an indefinite period of time and your authorization to use or disclose your PHI will not expire.

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study and for future research purposes (including purposes that are currently unknown) unless otherwise allowed by applicable laws. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers.

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this

Information collected for this study includes information that can identify you. This is called "protected health information" or PHI. By agreeing to be in this study, you are giving permission to this study team to collect, use, and disclose your PHI for this research study. Information collected is the property of Nationwide Children's Hospital, its affiliated entities, and/or the sponsor. Some of the information collected as part of this study will be sensitive, such as information relating to mood and behavior. PHI that may be used or disclosed: Names; Address; Telephone Numbers; Birth Date; E-mail Addresses/URLs; Medical Record Numbers. People or Companies authorized to use, disclose, and receive PHI collected or created by this research study: PI and study staff The Nationwide Children's Hospital Institutional Review Board (the committee that reviews all human subject research) Nationwide Children's Hospital internal auditors The Office for Human Research Protections (OHRP) (the federal government office that oversees human subject research)  
  
  
Because of the need to give information to these people, absolute confidentiality cannot be guaranteed. Information given to these people may be further disclosed by them and no longer be protected by federal privacy rules. Reason(s) why the use or disclosure is being made: For mentoring program matching, supervision and other communication; to ensure appropriate and complete data collection You may decide not to authorize the use and disclosure of your PHI. However, if it is needed for this study, you will not be able to be in this study. If you agree to be in this study and later decide to withdraw your participation, you may withdraw your authorization to use your PHI. This request must be made in writing to the Principal Investigator at 700 Children's Drive, Columbus, Ohio 43205. If you withdraw your authorization, no new PHI may be collected and the PHI already collected may not be used unless it has already been used or is needed to complete the study analysis and reports. PHI will only be shared with the groups listed above, but if you have a bad outcome or adverse event from being in this study, the study team or other health care providers may need to look at your entire medical records. The results from this study may be published but your identity will not be revealed. The PHI collected or created under this research study will be used or disclosed as needed until the end of the study. The records of this study will be kept for an indefinite period of time and your authorization to use or disclose your PHI will not expire.

To help us protect your privacy, the National Institutes of Health has issued a Certificate of Confidentiality for this study. This Certificate will be used to resist attempts to force us to disclose information that may identify you, even by a court subpoena, in any federal, state, or local civil, criminal, administrative, legislative, or other proceedings. The Certificate cannot be used to resist a demand for information that is used for auditing or evaluation of federally funded projects or for information that must be disclosed to meet the requirements of the Food and Drug Administration (FDA). A Certificate of Confidentiality does not prevent you or a member of your family from voluntarily releasing information about yourself or your participation in this research. If an insurer, employer, or other person obtains your written consent to receive research information, then we will release the information even though we have the Certificate of Confidentiality. The Certificate of Confidentiality also does not prevent us from disclosing voluntarily, without your consent, information that would identify you as a participant in the research if required by state and/or federal law. In Ohio, if we have reasonable knowledge that a felony has been or is being committed we are required to notify state officials. The Certificate does not protect study information that is placed into your medical records.
Clinical trial: NCT03827109
Section: Duration of Study Involvement
Subsections: 3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|3) Where Will The Study Be Done And How Many Subjects Will Take Part?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?|4) What Will Happen During The Study And How Long Will It Last?

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

Visit 1: Separately, parents and children will be asked to complete a set of questionnaires with a research assistant at Nationwide Children's Hospital or in their home at a time that is convenient for them. The questionnaires will take 1 - 1.5 hours to complete. The questionnaires will ask about behaviors, feelings, typical life activities, coping, and how IBD affects your life. You will also provide a stool sample for information about disease severity. We will send you a collection kit in the mail before the visit. Randomization: Next, you will be put into the mentoring program or the educational activity program. This study is randomized. Randomized means that each person will be picked by chance, like tossing a coin or drawing straws, to participate in the mentoring program or the education activity program. Each subject has a 50/50 (e.g., 1 in 2) chance of participating in the mentoring program and a 50/50 chance of participating in the education activity program. This lets us compare the subjects in the mentoring program to those who are not, to see if it is helpful.  
Educational Activity Program:  
(1) 3 educational group activities.  
IBD Nutrition Taking IBD to School Behind the Scenes at the GI Center
(2) A private website with information about living well with IBD. Information from the group activities will be posted here too. You will also be able to post questions that will be answered by project staff. (3) Monthly "check-in" phone call from the program coordinator. We will call you once a month to encourage you to "live well with IBD" by doing something fun with a friend.  
Mentoring Program: The mentoring program includes the educational activities plus:  
  
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have had IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors will check in with mentees every week (e.g., texting, phone call) and will have 6 in-person visits.  
(2) 3 fun activities Children and mentors nominate and vote on the activities to participate in. Previous activities include bowling, putt-putt golf, canoeing, laser tag, and ice skating.  
(3) A separate parent group.  
The parent group will occur during the youth group activities. The parent group will engage in formal self-management education during the mentor/mentee group activities and informal support. A separate, monitored online community will also be available for the parents for additional support.  
(4) The monthly "check-in" phone call for the mentoring group will focus on satisfaction and any concerns with the mentoring relationship and the mentoring program.
Visit 2: This is the same as Visit 1, and it will occur after your child has completed the program. We will also ask your permission to get attendance information from your school. The school will not be told what the study is about. A stool sample will be collected from you at this visit as well. Visit 3: 6 months after completing the program, we will send you a brief, online survey about the effect of IBD on your life and how you manage it. This will take about 20 minutes.

You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. Mentoring Program: The mentoring program has 4 parts:  
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.  
(2) Group activities that occur every other month.  
Some group activities are educational activities and others are solely "fun" activities.
(3) A private program website.  
This website has educational materials. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
(4) A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in" phone calls with program staff to talk about your experiences with your mentee. You will participate in weekly phone check-ins for the first month, then twice monthly check-ins. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time.  
  
  
Questionnaires: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program, the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

For mentors, there are two parts of the study, the application phase and the mentoring phase. This is the application phase. If you agree to be in the study, we will give you a website address where you will complete an online application and 3 questionnaires about the impact IBD has on your life. You will also give us 3 references for us to talk to, and you'll participate in an interview. Completing the application and questionnaires will take about 30 minutes, and the interview will be 30 minutes. Next, you'll complete our 3.5 hour orientation about the program. If you pass the screening, then you will be invited to participate in the mentoring program as a mentor. You will sign another consent form if you agree to be a mentor  
  
Mentoring Phase (second phase)
Mentoring Program: The Mentoring Program has 4 parts:  
1. A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.
2. Group activities that occur every month.  
Some group activities are educational activities and others are solely "fun" activities.  
3. A private program website.  
This website has educational materials and activity ideas for in-person get-togethers. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
4. A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in phone calls with program staff to talk about your experiences with your mentee. You will participate in twice monthly phone check-ins for the first 2 months, then monthly. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time.  
Questionnaires: You will complete questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program and the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. Mentoring Program: The mentoring program has 4 parts:
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.  
(2) Group activities that occur every other month.  
Some group activities are educational activities and others are solely "fun" activities.
(3) A private program website.  
This website has educational materials and activity ideas for in-person get-togethers. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
(4) A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in" phone calls with program staff to  
  
  
talk about your experiences with your mentee. You will participate in weekly phone check-ins for the first month, then twice monthly check-ins. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time. Questionnaires: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program, the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

Visit 1: Separately, parents and children will be asked to complete a set of questionnaires with a research assistant at Nationwide Children's Hospital or in their home at a time that is convenient for them. The questionnaires will take 1 - 1.5 hours to complete. The questionnaires will ask about behaviors, feelings, typical life activities, coping, and how IBD affects your life. You will also provide a stool sample for information about disease severity. We will send you a collection kit in the mail before the visit. Randomization: Next, you will be put into the mentoring program or the educational activity program. This study is randomized. Randomized means that each person will be picked by chance, like tossing a coin or drawing straws, to participate in the mentoring program or the education activity program. Each subject has a 50/50 (e.g., 1 in 2) chance of participating in the mentoring program and a 50/50 chance of participating in the education activity program. This lets us compare the subjects in the mentoring program to those who are not, to see if it is helpful.  
Educational Activity Program:  
(1) 3 educational group activities.  
IBD Nutrition Taking IBD to School Behind the Scenes at the GI Center
(2) A private website with information about living well with IBD. Information from the group activities will be posted here too. You will also be able to post questions that will be answered by project staff. (3) Monthly "check-in" phone call from the program coordinator. We will call you once a month to encourage you to "live well with IBD" by doing something fun with a friend.  
Mentoring Program: The mentoring program includes the educational activities plus:  
  
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have had IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors will check in with mentees every week (e.g., texting, phone call) and will have 6 in-person visits.  
(2) 3 fun activities Children and mentors nominate and vote on the activities to participate in. Previous activities include bowling, putt-putt golf, canoeing, laser tag, and ice skating.  
(3) A separate parent group.  
The parent group will occur during the youth group activities. The parent group will engage in formal self-management education during the mentor/mentee group activities and informal support. A separate, monitored online community will also be available for the parents for additional support.  
(4) The monthly "check-in" phone call for the mentoring group will focus on satisfaction and any concerns with the mentoring relationship and the mentoring program.
Visit 2: This is the same as Visit 1, and it will occur after your child has completed the program. We will also ask your permission to get attendance information from your school. The school will not be told what the study is about. A stool sample will be collected from you at this visit as well. Visit 3: 6 months after completing the program, we will send you a brief, online survey about the effect of IBD on your life and how you manage it. This will take about 20 minutes.

You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. Mentoring Program: The mentoring program has 4 parts:  
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.  
(2) Group activities that occur every other month.  
Some group activities are educational activities and others are solely "fun" activities.
(3) A private program website.  
This website has educational materials. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
(4) A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in" phone calls with program staff to talk about your experiences with your mentee. You will participate in weekly phone check-ins for the first month, then twice monthly check-ins. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time.  
  
  
Questionnaires: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program, the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

For mentors, there are two parts of the study, the application phase and the mentoring phase. This is the application phase. If you agree to be in the study, we will give you a website address where you will complete an online application and 3 questionnaires about the impact IBD has on your life. You will also give us 3 references for us to talk to, and you'll participate in an interview. Completing the application and questionnaires will take about 30 minutes, and the interview will be 30 minutes. Next, you'll complete our 3.5 hour orientation about the program. If you pass the screening, then you will be invited to participate in the mentoring program as a mentor. You will sign another consent form if you agree to be a mentor  
  
Mentoring Phase (second phase)
Mentoring Program: The Mentoring Program has 4 parts:  
1. A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.
2. Group activities that occur every month.  
Some group activities are educational activities and others are solely "fun" activities.  
3. A private program website.  
This website has educational materials and activity ideas for in-person get-togethers. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
4. A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in phone calls with program staff to talk about your experiences with your mentee. You will participate in twice monthly phone check-ins for the first 2 months, then monthly. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time.  
Questionnaires: You will complete questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program and the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. Mentoring Program: The mentoring program has 4 parts:
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.  
(2) Group activities that occur every other month.  
Some group activities are educational activities and others are solely "fun" activities.
(3) A private program website.  
This website has educational materials and activity ideas for in-person get-togethers. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
(4) A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in" phone calls with program staff to  
  
  
talk about your experiences with your mentee. You will participate in weekly phone check-ins for the first month, then twice monthly check-ins. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time. Questionnaires: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program, the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

Visit 1: Separately, parents and children will be asked to complete a set of questionnaires with a research assistant at Nationwide Children's Hospital or in their home at a time that is convenient for them. The questionnaires will take 1 - 1.5 hours to complete. The questionnaires will ask about behaviors, feelings, typical life activities, coping, and how IBD affects your life. You will also provide a stool sample for information about disease severity. We will send you a collection kit in the mail before the visit. Randomization: Next, you will be put into the mentoring program or the educational activity program. This study is randomized. Randomized means that each person will be picked by chance, like tossing a coin or drawing straws, to participate in the mentoring program or the education activity program. Each subject has a 50/50 (e.g., 1 in 2) chance of participating in the mentoring program and a 50/50 chance of participating in the education activity program. This lets us compare the subjects in the mentoring program to those who are not, to see if it is helpful.  
Educational Activity Program:  
(1) 3 educational group activities.  
IBD Nutrition Taking IBD to School Behind the Scenes at the GI Center
(2) A private website with information about living well with IBD. Information from the group activities will be posted here too. You will also be able to post questions that will be answered by project staff. (3) Monthly "check-in" phone call from the program coordinator. We will call you once a month to encourage you to "live well with IBD" by doing something fun with a friend.  
Mentoring Program: The mentoring program includes the educational activities plus:  
  
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have had IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors will check in with mentees every week (e.g., texting, phone call) and will have 6 in-person visits.  
(2) 3 fun activities Children and mentors nominate and vote on the activities to participate in. Previous activities include bowling, putt-putt golf, canoeing, laser tag, and ice skating.  
(3) A separate parent group.  
The parent group will occur during the youth group activities. The parent group will engage in formal self-management education during the mentor/mentee group activities and informal support. A separate, monitored online community will also be available for the parents for additional support.  
(4) The monthly "check-in" phone call for the mentoring group will focus on satisfaction and any concerns with the mentoring relationship and the mentoring program.
Visit 2: This is the same as Visit 1, and it will occur after your child has completed the program. We will also ask your permission to get attendance information from your school. The school will not be told what the study is about. A stool sample will be collected from you at this visit as well. Visit 3: 6 months after completing the program, we will send you a brief, online survey about the effect of IBD on your life and how you manage it. This will take about 20 minutes.

You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. Mentoring Program: The mentoring program has 4 parts:  
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.  
(2) Group activities that occur every other month.  
Some group activities are educational activities and others are solely "fun" activities.
(3) A private program website.  
This website has educational materials. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
(4) A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in" phone calls with program staff to talk about your experiences with your mentee. You will participate in weekly phone check-ins for the first month, then twice monthly check-ins. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time.  
  
  
Questionnaires: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program, the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

For mentors, there are two parts of the study, the application phase and the mentoring phase. This is the application phase. If you agree to be in the study, we will give you a website address where you will complete an online application and 3 questionnaires about the impact IBD has on your life. You will also give us 3 references for us to talk to, and you'll participate in an interview. Completing the application and questionnaires will take about 30 minutes, and the interview will be 30 minutes. Next, you'll complete our 3.5 hour orientation about the program. If you pass the screening, then you will be invited to participate in the mentoring program as a mentor. You will sign another consent form if you agree to be a mentor  
  
Mentoring Phase (second phase)
Mentoring Program: The Mentoring Program has 4 parts:  
1. A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.
2. Group activities that occur every month.  
Some group activities are educational activities and others are solely "fun" activities.  
3. A private program website.  
This website has educational materials and activity ideas for in-person get-togethers. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
4. A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in phone calls with program staff to talk about your experiences with your mentee. You will participate in twice monthly phone check-ins for the first 2 months, then monthly. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time.  
Questionnaires: You will complete questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program and the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. Mentoring Program: The mentoring program has 4 parts:
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.  
(2) Group activities that occur every other month.  
Some group activities are educational activities and others are solely "fun" activities.
(3) A private program website.  
This website has educational materials and activity ideas for in-person get-togethers. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
(4) A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in" phone calls with program staff to  
  
  
talk about your experiences with your mentee. You will participate in weekly phone check-ins for the first month, then twice monthly check-ins. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time. Questionnaires: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program, the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

This study will be done at several sites, including Nationwide Children's Hospital. Overall, we hope to enroll 100 mentors, 100 mentees, and 100 children in a comparison group.

Visit 1: Separately, parents and children will be asked to complete a set of questionnaires with a research assistant at Nationwide Children's Hospital or in their home at a time that is convenient for them. The questionnaires will take 1 - 1.5 hours to complete. The questionnaires will ask about behaviors, feelings, typical life activities, coping, and how IBD affects your life. You will also provide a stool sample for information about disease severity. We will send you a collection kit in the mail before the visit. Randomization: Next, you will be put into the mentoring program or the educational activity program. This study is randomized. Randomized means that each person will be picked by chance, like tossing a coin or drawing straws, to participate in the mentoring program or the education activity program. Each subject has a 50/50 (e.g., 1 in 2) chance of participating in the mentoring program and a 50/50 chance of participating in the education activity program. This lets us compare the subjects in the mentoring program to those who are not, to see if it is helpful.  
Educational Activity Program:  
(1) 3 educational group activities.  
IBD Nutrition Taking IBD to School Behind the Scenes at the GI Center
(2) A private website with information about living well with IBD. Information from the group activities will be posted here too. You will also be able to post questions that will be answered by project staff. (3) Monthly "check-in" phone call from the program coordinator. We will call you once a month to encourage you to "live well with IBD" by doing something fun with a friend.  
Mentoring Program: The mentoring program includes the educational activities plus:  
  
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have had IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors will check in with mentees every week (e.g., texting, phone call) and will have 6 in-person visits.  
(2) 3 fun activities Children and mentors nominate and vote on the activities to participate in. Previous activities include bowling, putt-putt golf, canoeing, laser tag, and ice skating.  
(3) A separate parent group.  
The parent group will occur during the youth group activities. The parent group will engage in formal self-management education during the mentor/mentee group activities and informal support. A separate, monitored online community will also be available for the parents for additional support.  
(4) The monthly "check-in" phone call for the mentoring group will focus on satisfaction and any concerns with the mentoring relationship and the mentoring program.
Visit 2: This is the same as Visit 1, and it will occur after your child has completed the program. We will also ask your permission to get attendance information from your school. The school will not be told what the study is about. A stool sample will be collected from you at this visit as well. Visit 3: 6 months after completing the program, we will send you a brief, online survey about the effect of IBD on your life and how you manage it. This will take about 20 minutes.

You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. Mentoring Program: The mentoring program has 4 parts:  
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.  
(2) Group activities that occur every other month.  
Some group activities are educational activities and others are solely "fun" activities.
(3) A private program website.  
This website has educational materials. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
(4) A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in" phone calls with program staff to talk about your experiences with your mentee. You will participate in weekly phone check-ins for the first month, then twice monthly check-ins. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time.  
  
  
Questionnaires: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program, the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

For mentors, there are two parts of the study, the application phase and the mentoring phase. This is the application phase. If you agree to be in the study, we will give you a website address where you will complete an online application and 3 questionnaires about the impact IBD has on your life. You will also give us 3 references for us to talk to, and you'll participate in an interview. Completing the application and questionnaires will take about 30 minutes, and the interview will be 30 minutes. Next, you'll complete our 3.5 hour orientation about the program. If you pass the screening, then you will be invited to participate in the mentoring program as a mentor. You will sign another consent form if you agree to be a mentor  
  
Mentoring Phase (second phase)
Mentoring Program: The Mentoring Program has 4 parts:  
1. A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.
2. Group activities that occur every month.  
Some group activities are educational activities and others are solely "fun" activities.  
3. A private program website.  
This website has educational materials and activity ideas for in-person get-togethers. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
4. A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in phone calls with program staff to talk about your experiences with your mentee. You will participate in twice monthly phone check-ins for the first 2 months, then monthly. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time.  
Questionnaires: You will complete questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program and the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.

You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. Mentoring Program: The mentoring program has 4 parts:
(1) A one-on-one relationship between a mentee and mentor.  
Mentors will be at least 16 years old, have IBD for at least one year, and will be extensively screened and trained. They will be matched to mentees based on gender, age, ethnicity, where they live, and interests if possible. Mentors and mentees are expected to have weekly contact (e.g., phone, text, videochat), and to meet in person 1 - 2 times per month for 1 year.  
(2) Group activities that occur every other month.  
Some group activities are educational activities and others are solely "fun" activities.
(3) A private program website.  
This website has educational materials and activity ideas for in-person get-togethers. You will be given log-in information for it. Private, secure messages can be sent to program staff if you have questions about the information.  
(4) A separate parent group.  
The parent group will meet during the mentor/mentee group activities for education and support.
Mentor Orientation and Supervision: You will complete our 3.5 hour mentor orientation before being matched with a mentee, and you will participate in regular "check-in" phone calls with program staff to  
  
  
talk about your experiences with your mentee. You will participate in weekly phone check-ins for the first month, then twice monthly check-ins. We think that each phone call will last 10-15 minutes. Mentors can always contact program staff for help or advice at any time. Questionnaires: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will ask about your satisfaction with the program, the effect of your IBD on your life and how you manage it. The questionnaires will take about 15 minutes to complete.
Clinical trial: NCT03827109
Section: Possible Risks, Discomforts, and Inconveniences
Subsections: 5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|5) What Are The Risks Of Being In This Study?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?|9) What Happens If Being In This Study Causes Injuries?

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time. Mentoring Program There is a risk of emotional or physical harm for mentees in the mentoring program. Big Brothers Big Sisters (BBBS) states they get reports about this happening for less than 1% of children in their program per year.  
  
  
We have worked with BBBS and are taking every precaution to minimize this risk. We are following their recommendations and expanding them in several ways. We rigorously screen mentors with a written application based on the one used by BBBS, background checks, an interview, and references. Mentors are extensively trained with BBBS and other mentoring training materials. Mentors are closely supervised, and all group activities are supervised by project staff. Finally, mentees and parents are contacted monthly to identify any concerns, and they may contact project staff at any time. The amount of supervision we are requiring for mentors in this program is more than BBBS requires in its programs. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time. Mentoring Program There is a risk of emotional or physical harm for mentees in the mentoring program. Big Brothers Big Sisters (BBBS) states they get reports about this happening for less than 1% of children in their program per year.  
  
  
We have worked with BBBS and are taking every precaution to minimize this risk. We are following their recommendations and expanding them in several ways. We rigorously screen mentors with a written application based on the one used by BBBS, background checks, an interview, and references. Mentors are extensively trained with BBBS and other mentoring training materials. Mentors are closely supervised, and all group activities are supervised by project staff. Finally, mentees and parents are contacted monthly to identify any concerns, and they may contact project staff at any time. The amount of supervision we are requiring for mentors in this program is more than BBBS requires in its programs. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you/your child is hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and call the study team as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department.  
  
  
In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you or your child are hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and tell the Study Doctor as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you or your child are hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and tell the Study Doctor as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you are hurt by the procedures that are part of the study, you should seek medical treatment for the injuries and call the study team as soon as possible at the number on page 1 of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time. Mentoring Program There is a risk of emotional or physical harm for mentees in the mentoring program. Big Brothers Big Sisters (BBBS) states they get reports about this happening for less than 1% of children in their program per year.  
  
  
We have worked with BBBS and are taking every precaution to minimize this risk. We are following their recommendations and expanding them in several ways. We rigorously screen mentors with a written application based on the one used by BBBS, background checks, an interview, and references. Mentors are extensively trained with BBBS and other mentoring training materials. Mentors are closely supervised, and all group activities are supervised by project staff. Finally, mentees and parents are contacted monthly to identify any concerns, and they may contact project staff at any time. The amount of supervision we are requiring for mentors in this program is more than BBBS requires in its programs. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you/your child is hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and call the study team as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department.  
  
  
In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you or your child are hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and tell the Study Doctor as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you or your child are hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and tell the Study Doctor as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you are hurt by the procedures that are part of the study, you should seek medical treatment for the injuries and call the study team as soon as possible at the number on page 1 of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time. Mentoring Program There is a risk of emotional or physical harm for mentees in the mentoring program. Big Brothers Big Sisters (BBBS) states they get reports about this happening for less than 1% of children in their program per year.  
  
  
We have worked with BBBS and are taking every precaution to minimize this risk. We are following their recommendations and expanding them in several ways. We rigorously screen mentors with a written application based on the one used by BBBS, background checks, an interview, and references. Mentors are extensively trained with BBBS and other mentoring training materials. Mentors are closely supervised, and all group activities are supervised by project staff. Finally, mentees and parents are contacted monthly to identify any concerns, and they may contact project staff at any time. The amount of supervision we are requiring for mentors in this program is more than BBBS requires in its programs. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further.

We believe that there is very little chance that bad things will happen as a result of being in this study. It is possible that you could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. If you do find any of the questions upsetting or don't want to answer a question, you don't have to, and the study coordinator will be available to discuss this with you further. There is also a risk of loss of confidentiality (privacy), since participants will be engaging in group activities with other participants, sharing information with mentors and potentially sharing information through social media. Other people attending the group activities will know that you have IBD, and social media may not be private. Confidentiality will be emphasized in mentor training and supervision, and during the mentee orientation. We will also remind everyone about confidentiality at each group activity. If participants feel uncomfortable at any time, they can call the mentoring program Urgent Response number, 614-722-4745, and/or leave the activity. There is a risk that the web-based components of the study could be "hacked." This risk is low due to all of the security precautions used by NCH. There may be other risks of being in this research study that are not known at this time.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you/your child is hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and call the study team as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department.  
  
  
In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you or your child are hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and tell the Study Doctor as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you or your child are hurt by the procedures that are part of the Study, you should seek medical treatment for the injuries and tell the Study Doctor as soon as possible at the number on the first page of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.

We believe that there is very little chance that injuries will happen as a result of being in this study. If you are hurt by the procedures that are part of the study, you should seek medical treatment for the injuries and call the study team as soon as possible at the number on page 1 of this form. If it is an emergency, call 911 or go to the nearest emergency department. In most cases, this care will be billed to your health insurance company or whoever usually pays for your health care at the usual charges, but some insurance companies will not pay for care related to a study. If the care is provided at Nationwide Children's Hospital, we make no commitment to pay for the medical care provided to you. No funds have been set aside to compensate you in the event of injury. If no one else pays for your care, you may have to pay for the cost of this care. This does not mean that you give up any of your legal rights to seek compensation for your injuries.
Clinical trial: NCT03827109
Section: Purpose of Research
Subsections: 1) Introduction|1) Introduction|1) Introduction|Key Information About This Study|Key Information About This Study|1) Introduction|1) Introduction|1) Introduction|Key Information About This Study|Key Information About This Study|1) Introduction|1) Introduction|1) Introduction

We invite you to be in this research study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree to be in  
  
  
this study. If you do not want to be in this study, all regular and standard medical care will still be available to you at Nationwide Children's Hospital or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form and assent form.

We invite you to apply to be a mentor in this study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
to be in this study. If you do not want to be in this study, all regular and standard medical care will still be available to you here or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form.

We invite you to be in this research study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree to be in this study. If you do not want to be in this study, all regular and standard medical care will still be available to you at Nationwide Children's Hospital or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form.

The following is a short summary of this study to help you decide whether or not to participate. More detailed information follows later in this form. The purpose of this study is to is to find out if a mentoring program helps youth live well with IBD. We invite you to apply to be a mentor in this study. Study participation: For mentors, there are two parts of the study, the application phase and the mentoring phase. This is the application phase. You will complete an online application and 3 questionnaires. You will also give us 3 references, and you'll participate in an interview. Completing the application and questionnaires will take about 30 minutes, and the interview will be 30 minutes. Next, you'll complete our 3.5 hour orientation about the program. If you pass the screening, then you will be invited to participate in the mentoring program as a mentor. See a more detailed discussion later in this form. The main risks of this part of the study are: You could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. The benefit(s) of the study are: For this application phase of the study, we might learn something that If you are interested in learning more about this study, please continue reading below.

The following is a short summary of this study to help you decide whether or not to participate. More detailed information follows later in this form. The purpose of this study is to see if a mentoring program helps youth live well with IBD. Study participation: You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. You will have a 1:1 relationship with a mentee, which will include weekly contact (e.g., phone, text, videochat) and in person contact 1 - 2 times per month. There are also group activities for mentors and mentees, and you will check in with the Program Coordinator on a regular basis. Study visits: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will take about 15 minutes to complete. See a more detailed discussion later in this form. The main risk of the study is loss of confidentiality (privacy), since participants will be engaging in group activities with other participants and potentially sharing personal information. Other risks are listed later in this form. The benefit(s) of the study are: You might learn new things about IBD and how to manage it, and you might meet other supportive people. You might help someone else learn how to better manage the impact of IBD. If you are interested in learning more about this study, please continue reading below.

We invite you to be in this research study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree to be in  
  
  
this study. If you do not want to be in this study, all regular and standard medical care will still be available to you at Nationwide Children's Hospital or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form and assent form.

We invite you to apply to be a mentor in this study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
to be in this study. If you do not want to be in this study, all regular and standard medical care will still be available to you here or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form.

We invite you to be in this research study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree to be in this study. If you do not want to be in this study, all regular and standard medical care will still be available to you at Nationwide Children's Hospital or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form.

The following is a short summary of this study to help you decide whether or not to participate. More detailed information follows later in this form. The purpose of this study is to is to find out if a mentoring program helps youth live well with IBD. We invite you to apply to be a mentor in this study. Study participation: For mentors, there are two parts of the study, the application phase and the mentoring phase. This is the application phase. You will complete an online application and 3 questionnaires. You will also give us 3 references, and you'll participate in an interview. Completing the application and questionnaires will take about 30 minutes, and the interview will be 30 minutes. Next, you'll complete our 3.5 hour orientation about the program. If you pass the screening, then you will be invited to participate in the mentoring program as a mentor. See a more detailed discussion later in this form. The main risks of this part of the study are: You could feel upset when answering questions about your diagnosis or medical treatment, but it may be more likely that you find the questions a little boring. The benefit(s) of the study are: For this application phase of the study, we might learn something that If you are interested in learning more about this study, please continue reading below.

The following is a short summary of this study to help you decide whether or not to participate. More detailed information follows later in this form. The purpose of this study is to see if a mentoring program helps youth live well with IBD. Study participation: You will participate in the mentoring program as a mentor for one year, and you will complete questionnaires to evaluate it. You will have a 1:1 relationship with a mentee, which will include weekly contact (e.g., phone, text, videochat) and in person contact 1 - 2 times per month. There are also group activities for mentors and mentees, and you will check in with the Program Coordinator on a regular basis. Study visits: You will complete 3 online questionnaires to see if the mentoring program is helpful 12 months after you meet your mentee. The questionnaires will take about 15 minutes to complete. See a more detailed discussion later in this form. The main risk of the study is loss of confidentiality (privacy), since participants will be engaging in group activities with other participants and potentially sharing personal information. Other risks are listed later in this form. The benefit(s) of the study are: You might learn new things about IBD and how to manage it, and you might meet other supportive people. You might help someone else learn how to better manage the impact of IBD. If you are interested in learning more about this study, please continue reading below.

We invite you to be in this research study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree to be in  
  
  
this study. If you do not want to be in this study, all regular and standard medical care will still be available to you at Nationwide Children's Hospital or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form and assent form.

We invite you to apply to be a mentor in this study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
to be in this study. If you do not want to be in this study, all regular and standard medical care will still be available to you here or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form.

We invite you to be in this research study. Using this form as a guide, we will explain the study to you. If you have any questions about the study, please ask. By signing this form, you agree to be in this study. If you do not want to be in this study, all regular and standard medical care will still be available to you at Nationwide Children's Hospital or at another institution. Participation is voluntary. You can leave this study at any time. You will be given a signed and dated copy of the consent form.
Clinical trial: NCT03827109
Section: Withdrawal from Study
Subsections: 10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|11) Other Important Information|11) Other Important Information|11) Other Important Information|11) Other Important Information|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?|10) What Happens If I Do Not Finish This Study?

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study. Please see the Crohn's and Colitis Connect Mentoring Program Procedures Manual for procedures for stopping your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. You can participate in this application phase and then say no to the mentoring phase. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled.  
If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study. Please see the Crohn's and Colitis Connect Mentoring Program Procedures Manual for procedures for stopping your participation in the study.

If you are an employee of Nationwide Children's Hospital or the Research Institute at Nationwide Children's Hospital, your job or performance appraisal will not be affected in any way if you decline to participate or withdraw your consent to participate in this study. A description of this clinical trial will be available on www.ClinicalTrials.gov, as required by U.S. Law. This Website will not include information that can identify you. At most, the Website will include a summary of the results. You can search this web site at any time. The final study results will not be shared with you individually. However, at some time, a final study summary will be available on the ClinicalTrials.Gov (http://clinicaltrials.gov) website. The Principal Investigator is being paid by NIH for the time and knowledge needed to do this study. Nationwide Children's Hospital is a teaching hospital and we are committed to doing research. Doing research will enable us to learn and provide the best care for our patients and families. You may be asked to participate in other research studies in the future. You have the right to decide to participate or decline to participate in any future studies. We will not share your contact information with researchers outside Nationwide Children's Hospital. Some people have asked us to text them study-related reminders rather than calling them. Information sent and received via text message may not be private and individuals unrelated to this study could obtain the information in the messages. Would you like us to text you or to call you? Initial: ____ I authorize study staff to contact me via text message. I understand that information sent and received via text message may not be private and individuals unrelated to this study could obtain the information in the messages. ____ I do not authorize study staff to contact me via text message. I prefer to be called.

If you are an employee of Nationwide Children's Hospital or the Research Institute at Nationwide Children's Hospital, your job or performance appraisal will not be affected in any way if you decline to participate or withdraw your consent to participate in this study. A description of this clinical trial will be available on www.ClinicalTrials.gov, as required by U.S. Law. This Website will not include information that can identify you. At most, the Website will include a summary of the results. You can search this web site at any time. The final study results will not be shared with you individually. However, at some time, a final study summary will be available on the ClinicalTrials.Gov (http://clinicaltrials.gov) website. The Principal Investigator is being paid by NIH for the time and knowledge needed to do this study.  
  
  
Nationwide Children's Hospital is a teaching hospital and we are committed to doing research. Doing research will enable us to learn and provide the best care for our patients and families. You may be asked to participate in other research studies in the future. You have the right to decide to participate or decline to participate in any future studies. We will not share your contact information with researchers outside Nationwide Children's Hospital. Some people have asked us to text them study-related reminders rather than calling them. Information sent and received via text message may not be private and individuals unrelated to this study could obtain the information in the messages. Would you like us to text you or to call you? Initial: ____ I authorize study staff to contact me via text message. I understand that information sent and received via text message may not be private and individuals unrelated to this study could obtain the information in the messages. ____ I do not authorize study staff to contact me via text message. I prefer to be called.

If you are an employee of Nationwide Children's Hospital or the Research Institute at Nationwide Children's Hospital, your job or performance appraisal will not be affected in any way if you decline to participate or withdraw your consent to participate in this study. A description of this clinical trial will be available on www.ClinicalTrials.gov, as required by U.S. Law. This Website will not include information that can identify you. At most, the Website will include a summary of the results. You can search this web site at any time. The final study results will not be shared with you individually. However, at some time, a final study summary will be available on the ClinicalTrials.Gov (http://clinicaltrials.gov) website. The Principal Investigator is being paid by NIH for the time and knowledge needed to do this study. Nationwide Children's Hospital is a teaching hospital and we are committed to doing research. Doing research will enable us to learn and provide the best care for our patients and families. You may be asked to participate in other research studies in the future. You have the right to decide to participate or decline to participate in any future studies. We will not share your contact information with researchers outside Nationwide Children's Hospital.  
STUDY TITLE: Peer Mentoring to Improve Self-Management in Youth with IBD  
  
  
  
Some people have asked us to text them study-related reminders rather than calling them. Information sent and received via text message may not be private and individuals unrelated to this study could obtain the information in the messages. Would you like us to text you or to call you?

If you are an employee of Nationwide Children's Hospital or the Research Institute at Nationwide Children's Hospital, your job or performance appraisal will not be affected in any way if you decline to participate or withdraw your consent to participate in this study.  
  
  
A description of this clinical trial will be available on www.ClinicalTrials.gov, as required by U.S. Law. This Website will not include information that can identify you. At most, the Website will include a summary of the results. You can search this web site at any time. The final study results will not be shared with you individually. However, at some time, a final study summary will be available on the ClinicalTrials.Gov (http://clinicaltrials.gov) website. The Principal Investigator is being paid by NIH for the time and knowledge needed to do this study. Nationwide Children's Hospital is a teaching hospital and we are committed to doing research. Doing research will enable us to learn and provide the best care for our patients and families. You may be asked to participate in other research studies in the future. You have the right to decide to participate or decline to participate in any future studies. We will not share your contact information with researchers outside Nationwide Children's Hospital. Some people have asked us to text them study-related reminders rather than calling them. Information sent and received via text message may not be private and individuals unrelated to this study could obtain the information in the messages. Would you like us to text you or to call you? Initial: ____ I authorize study staff to contact me via text message. I understand that information sent and received via text message may not be private and individuals unrelated to this study could obtain the information in the messages. ____ I do not authorize study staff to contact me via text message. I prefer to be called.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study. Please see the Crohn's and Colitis Connect Mentoring Program Procedures Manual for procedures for stopping your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. You can participate in this application phase and then say no to the mentoring phase. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled.  
If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study. Please see the Crohn's and Colitis Connect Mentoring Program Procedures Manual for procedures for stopping your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study. Please see the Crohn's and Colitis Connect Mentoring Program Procedures Manual for procedures for stopping your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. You can participate in this application phase and then say no to the mentoring phase. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled.  
If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study. Please see the Crohn's and Colitis Connect Mentoring Program Procedures Manual for procedures for stopping your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study. Please see the Crohn's and Colitis Connect Mentoring Program Procedures Manual for procedures for stopping your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled. You can participate in this application phase and then say no to the mentoring phase. If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study.

It is your choice to be in this study. You may decide to stop being in this study at any time. If you decide to stop being in this study, call the study team at the number on page 1 of this form. If you stop being in the study, there will be no penalty or loss of benefits to which you are otherwise entitled.  
If at any time the Principal Investigator believes that this study is not good for you, the study team will contact you about stopping. If the study instructions are not followed, participation in the study may also be stopped. If unexpected problems come up, the Principal Investigator or the Sponsor, (NIH), may decide to stop your participation in the study. Please see the Crohn's and Colitis Connect Mentoring Program Procedures Manual for procedures for stopping your participation in the study.